Schedule 13D ownership disclosure

INDAPTUS THERAPEUTICS INC

Common Stock, $0.01 par value · CUSIP: 45339J105

Event date: 2026-03-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Yao YunReported CIK 0002120637

    Shares: 41,991,000.00 · Class: 37.8%

  • SINO LION VENTURES LtdReported CIK 0002120638

    Shares: 38,895,000.00 · Class: 35.0%

  • Xu Chenhao

    Shares: 38,895,000.00 · Class: 35.0%

  • Dai JunyiReported CIK 0002022463

    Shares: 11,250,000.00 · Class: 10.1%

  • Yang TingReported CIK 0002120636

    Shares: 11,250,000.00 · Class: 10.1%

  • Deng LinaReported CIK 0002120635

    Shares: 5,550,000.00 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001829126-26-002858
Form type
SCHEDULE 13D
Filer
Indaptus Therapeutics, Inc.
CIK
CIK 1857044
Filed
Mar 30, 2026
Reporting period
Mar 23, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub